NanoString Technologies Inc - ESG Rating & Company Profile powered by AI
If you are employed by NanoString Technologies Inc and you would like to use your ESG rating, please get in touch. This webpage includes a Q&A table about NanoString Technologies Inc. Alternative corporations in the rating peer group for NanoString Technologies Inc are displayed.
NanoString Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 6.7, social score of 5.7 and governance score of 8.0.
6.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
294 | SMS Pharmaceuticals Ltd | 6.9 | High |
294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
314 | NanoString Technologies Inc | 6.8 | High |
314 | Camurus AB | 6.8 | High |
314 | Cassiopea SpA | 6.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does NanoString Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does NanoString Technologies Inc disclose current and historical energy intensity?
Does NanoString Technologies Inc report the average age of the workforce?
Does NanoString Technologies Inc reference operational or capital allocation in relation to climate change?
Does NanoString Technologies Inc disclose its ethnicity pay gap?
Does NanoString Technologies Inc disclose cybersecurity risks?
Does NanoString Technologies Inc offer flexible work?
Does NanoString Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does NanoString Technologies Inc disclose the number of employees in R&D functions?
Does NanoString Technologies Inc conduct supply chain audits?
Does NanoString Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does NanoString Technologies Inc conduct 360 degree staff reviews?
Does NanoString Technologies Inc disclose the individual responsible for D&I?
Does NanoString Technologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does NanoString Technologies Inc disclose current and / or historical scope 2 emissions?
Does NanoString Technologies Inc disclose water use targets?
Does NanoString Technologies Inc have careers partnerships with academic institutions?
Did NanoString Technologies Inc have a product recall in the last two years?
Does NanoString Technologies Inc disclose incidents of discrimination?
Does NanoString Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Has NanoString Technologies Inc issued a profit warning in the past 24 months?
Does NanoString Technologies Inc disclose parental leave metrics?
Does NanoString Technologies Inc disclose climate scenario or pathway analysis?
Does NanoString Technologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does NanoString Technologies Inc disclose the pay ratio of women to men?
Does NanoString Technologies Inc support suppliers with sustainability related research and development?
Does NanoString Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does NanoString Technologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is NanoString Technologies Inc involved in embryonic stem cell research?
Does NanoString Technologies Inc disclose GHG and Air Emissions intensity?
Does NanoString Technologies Inc disclose its waste policy?
Does NanoString Technologies Inc report according to TCFD requirements?
Does NanoString Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does NanoString Technologies Inc disclose energy use targets?
Does NanoString Technologies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does NanoString Technologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for NanoString Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.